MIRA Pharmaceuticals, Inc.MIRANASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank60
3Y CAGR+0.3%
5Y CAGR+153.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.3%/yr
Annual compound
5Y CAGR
+153.7%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
105.1x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.11M | -11.4% |
| 2024 | $8.02M | -6.0% |
| 2023 | $8.53M | +21.0% |
| 2022 | $7.05M | +227.5% |
| 2021 | $2.15M | +3082.3% |
| 2020 | $67629.00 | - |